Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/28/2003WO2002034922A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
08/28/2003WO2002033126A3 Solid support assay systems and methods utilizing non-standard bases
08/28/2003WO2002033088A3 Human carboxypeptidase, scramblase, and protocadherin family members and uses thereof
08/28/2003WO2002030977A3 Egf motif protein, egfl6 materials and methods
08/28/2003WO2002029097A3 Methods relating to polymorphisms in the human gpr10 gene
08/28/2003WO2002027035A3 High-throughput gene cloning and phenotypic screening
08/28/2003WO2002026818A3 Human nedd-1
08/28/2003WO2002020756A3 Secretory molecules
08/28/2003WO2002020050A3 Eiav p26 deletion vaccine and diagnostic
08/28/2003WO2002018948A3 Differentially expressed epitopes and uses thereof
08/28/2003WO2002012499A3 Haplotypes of the ntf3 gene
08/28/2003WO2002012498A3 Haplotypes of the isl1 gene
08/28/2003WO2002012470A3 A member of the lysyl oxidase gene family
08/28/2003WO2002012342A3 Haplotypes of the edg4 gene
08/28/2003WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
08/28/2003WO2002008433A3 Acyl coenzyme a thioesterases
08/28/2003WO2002008399A3 Human kinases
08/28/2003WO2002008274A3 56939, a human acyl-coa thioesterase family member and uses thereof
08/28/2003WO2002007752A3 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
08/28/2003WO2002002823A3 Polynucleotide sequence assay
08/28/2003WO2002002780A3 Human serine-threonine kinase
08/28/2003WO2002000938A3 Methods and compositions for transcription-based nucleic acid amplification
08/28/2003WO2002000896A3 Method for transformation of agaricus bisporus
08/28/2003WO2001096875A3 Hcv antigen/antibody combination assay
08/28/2003WO2001092307A3 Therapeutic compounds for ovarian cancer
08/28/2003WO2001079489A3 39228, a human alcohol dehydrogenase and uses therefor
08/28/2003WO2001068831A3 Effective nuclear reprogramming in mammals
08/28/2003US20030163856 Genetic engineering of gene expression, disenabling ATP production in the mitochondria of plants; antifertility treatment
08/28/2003US20030163851 Plant having improved tolerance to various environmental stresses, method of constructing the same and polyamine metabolism-relating enzyme gene
08/28/2003US20030163850 Polypeptides; transgenic plant; stress tolerance
08/28/2003US20030163849 Plant gene targeting using oligonucleotides
08/28/2003US20030163848 Methods of commercial production and extraction of protein from seed
08/28/2003US20030163847 Reversible male sterility in transgenic plants by expression of cytokinin oxidase
08/28/2003US20030163846 Process for the genetic modification of a plant
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030163844 Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants
08/28/2003US20030163843 Reduced concentration of fiber; yellow seeds
08/28/2003US20030163842 Novel plant receptor-like kinases
08/28/2003US20030163841 Better emergence characteristics and improved seedling growth under low-light environments
08/28/2003US20030163840 Genetic engineering; modulation Dna metabolism
08/28/2003US20030163839 Genetic engineering; polypeptide; transgenic plants
08/28/2003US20030163838 Adjusting concentration of cellulose synthase in plants; genetic engineering
08/28/2003US20030163837 Genetic engineering; transgenic plants
08/28/2003US20030163836 In situ detection of enzyme inhibitors
08/28/2003US20030163835 Hydrogen peroxide lyase regulatory region
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162949 Stabilization; administering by injection
08/28/2003US20030162947 Rapid production of monoclonal antibodies
08/28/2003US20030162946 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162943 Antibodies to polypeptide molecules of the G protein-coupled heptahelical receptor superfamily and uses therefor
08/28/2003US20030162942 Binding to ligand; adjustment of pH; elution
08/28/2003US20030162853 Lysis of plasmids with fluoropolymer; liquid chromatography
08/28/2003US20030162741 Oral DNA composition for hepatitis B virus chronic infection
08/28/2003US20030162739 Antisense molecules and method of controlling expression of gene function by using the same
08/28/2003US20030162738 Antigenic composition comprising a polycationic peptide and inosine and cytosine
08/28/2003US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein
08/28/2003US20030162734 Inhibiting interaction of antisense nucleotides with jun-N-terminal kinases (JNKs) via administering 4-(4-fluoro-phenyl)-2-(4-methlysulfinylphenyl)-5-(4-pyridyl)-1H-imidazole; stem cells
08/28/2003US20030162718 Antigrowth agents; microbiocides, bactericides
08/28/2003US20030162714 Modulate cell differentiation; muscular disorders; fat metabolism; bone disorders
08/28/2003US20030162713 Genetic engineering; contorlling gene expression
08/28/2003US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains
08/28/2003US20030162294 Genes involved in tolerance to environmental stress
08/28/2003US20030162293 Cell transfection compositions comprising genetic material, an amphipathic compound and an enzyme inhibitor and method of use
08/28/2003US20030162292 Transgenic zebrafish (models) comprising plasmid for green fluorescent protein integrated within genome for analyzing heart-related gene functions and gene therapy
08/28/2003US20030162291 Clk-2, cex-7 and coq-4 genes, and uses thereof
08/28/2003US20030162290 Method for inducing differentiation of embryonic stem cells into functioning cells
08/28/2003US20030162285 Comprises pressing of reaction solution into reaction chamber; centrifuging-free; polymerase chain reactions
08/28/2003US20030162280 Enzyme isolated from a Bifidobacterium
08/28/2003US20030162279 22438, 23553, 25278, and 26212 novel human sulfatases
08/28/2003US20030162278 Use for development of human therapeutic proteins; amino acid sequences, allelic variants, isolated polypeptide, antibody and nucleic acids, transgenic non-human animal, culturing the host cell, genetic engineering
08/28/2003US20030162277 Calcium/calmodulin-dependent kinase
08/28/2003US20030162274 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003US20030162273 Modulation of sulfate permease for photosynthetic hydrogen production
08/28/2003US20030162271 Homologous recombination; transposition; comprises xylose isomerase, xylulokinase, transketolase, and transaldolase; for production of ethanol
08/28/2003US20030162269 Strains additional genes chosen from dapA gene (dihydrodipicolinate synthase gene), lysC gene (aspartate kinase gene), lysE gene (lysine export carrier gene), dapB gene (dihydrodipicolinate reductase gene), are over-expressed
08/28/2003US20030162266 When the primers hybridize to each other, the 3' terminal residue of one primer forms a mismatch with the altered or mutated nucleotide residue on the other primer, thus preventing primer extension
08/28/2003US20030162265 Dna joining method
08/28/2003US20030162264 Method and reagent for treatment of diseases caused by expression of the c-myc gene
08/28/2003US20030162263 Specific peptide of 6 to 40 amino acids and is capable of giving rise to antibodies which inhibit superantigen activity associated with HERV-K18 (human endogenous retrovirus) localized in intron 1 of CD48 gene on chromosome 1
08/28/2003US20030162262 A recombinant host cell, which in its untransformed state does not produce narbonolide, that consists of a recombinant DNA expression vector that encodes a narbonolide (polyketide synthase) PKS and produces narbonolide
08/28/2003US20030162256 PTH1R and PTH3R receptors, methods and uses thereof
08/28/2003US20030162254 NaPi type IIb polypeptides and methods for making and using same
08/28/2003US20030162253 Recombinant plasmid psp1, microorganisms transformed therewith, and method for producing an alkaline protease vapk
08/28/2003US20030162252 Isolating cDNAs encoding novel G protein-coupled receptor proteins derived from human spleen
08/28/2003US20030162250 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/28/2003US20030162249 Providing a culture of bacterial cells, adding rhanmose to the culture to induce rhamnose promoter whereby the antibody heavy chain and light chain and their linked signal sequences are expressed, secreted to the periplasm
08/28/2003US20030162247 32164 protein, a novel seven transmembrane protein
08/28/2003US20030162245 General means of labeling protein by using wheat embryo cell-free protein synthesis system
08/28/2003US20030162238 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
08/28/2003US20030162229 Immuno-interactive fragments of the alpha-C subunit of inhibin
08/28/2003US20030162225 Ligands specific for an isoform of the prion protein
08/28/2003US20030162223 Detection of insecticide; determination, calibration of binding to protein
08/28/2003US20030162220 Detecting human infant kidney tumor; genetic engineered polypeptide
08/28/2003US20030162218 High-throughput screening of expressed DNA libraries in filamentous fungi
08/28/2003US20030162217 Method of identifying nucleic acids
08/28/2003US20030162216 Nucleic acid ligand diagnostic biochip
08/28/2003US20030162215 Using semiconductor nanoparticles; biopolymer labeled with avidin, biotin
08/28/2003US20030162210 Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids